BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29845406)

  • 21. Ipsilateral Central Neck Dissection Plus Frozen Section Examination Versus Prophylactic Bilateral Central Neck Dissection in cN0 Papillary Thyroid Carcinoma.
    Raffaelli M; De Crea C; Sessa L; Fadda G; Bellantone C; Lombardi CP
    Ann Surg Oncol; 2015 Jul; 22(7):2302-8. PubMed ID: 25652046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.
    Ito Y; Miyauchi A; Masuoka H; Fukushima M; Kihara M; Miya A
    World J Surg; 2018 Aug; 42(8):2462-2468. PubMed ID: 29372373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.
    Piccardo A; Puntoni M; Bottoni G; Treglia G; Foppiani L; Bertoli M; Catrambone U; Arlandini A; Dib B; Altrinetti V; Massollo M; Bossert I; Cabria M; Bertagna F; Giovanella L
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):926-934. PubMed ID: 27966046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of central lymph node dissection for papillary thyroid carcinoma in cN0 T1/T2].
    Zhao SY; Ma YH; Yin Z; Zhan XX; Cheng RC; Qian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):105-109. PubMed ID: 29429179
    [No Abstract]   [Full Text] [Related]  

  • 25. [Significance of selective neck dissection in patients with cN0 thyroid carcinoma].
    Li ZJ; An CM; Yan DG; Zhang XW; Zhang ZM; Xu ZG; Tang PZ
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):783-6. PubMed ID: 24378103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.
    Wu SS; Joshi N; Sharrett J; Rao S; Shah A; Scharpf J; Burkey B; Lamarre ED; Prendes B; Siperstein A; Shin J; Berber E; Jin J; Krishnamurthi V; Nasr C; Hong L; Buchberger DS; Woody N; Koyfman SA; Geiger JL
    JAMA Otolaryngol Head Neck Surg; 2023 Jan; 149(1):79-86. PubMed ID: 36454559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guiding the postoperative radioactive iodine-131 therapy for patients with papillary thyroid carcinoma according to the prognostic risk groups: a SEER-based study.
    Yang Y; Gan M; Yi K; Han S; Lin Z; Shi Y; Ming J
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17147-17157. PubMed ID: 37782329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection.
    Laird AM; Gauger PG; Miller BS; Doherty GM
    World J Surg; 2012 Jun; 36(6):1268-73. PubMed ID: 22270997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival.
    Moreno MA; Edeiken-Monroe BS; Siegel ER; Sherman SI; Clayman GL
    Thyroid; 2012 Apr; 22(4):347-55. PubMed ID: 22280230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma.
    Giordano D; Frasoldati A; Gabrielli E; Pernice C; Zini M; Castellucci A; Piana S; Ciarrocchi A; Cavuto S; Barbieri V
    Am J Otolaryngol; 2017; 38(5):576-581. PubMed ID: 28599790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
    Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
    Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.
    Bonnet S; Hartl D; Leboulleux S; Baudin E; Lumbroso JD; Al Ghuzlan A; Chami L; Schlumberger M; Travagli JP
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1162-7. PubMed ID: 19116234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma.
    Hu D; Zhou J; He W; Peng J; Cao Y; Ren H; Mao Y; Dou Y; Xiong W; Xiao Q; Su X
    World J Surg Oncol; 2018 Feb; 16(1):30. PubMed ID: 29439716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
    Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
    Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of adjuvant radioactive iodine therapy with survival in node-positive papillary thyroid cancer.
    Sun Y; Gong J; Guo B; Shang J; Cheng Y; Xu H
    Oral Oncol; 2018 Dec; 87():152-157. PubMed ID: 30527231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Implications of Lymph Node Yield in Central and Lateral Neck Dissections for Well-Differentiated Papillary Thyroid Carcinoma.
    Heaton CM; Chang JL; Orloff LA
    Thyroid; 2016 Mar; 26(3):434-40. PubMed ID: 26825749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.